These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17613459)

  • 41. Changes in practice since the publication in 2007 of further results from the Women's Health Initiative and the Million Women Study.
    Cust MP
    Menopause Int; 2007 Dec; 13(4):141-3. PubMed ID: 18088523
    [No Abstract]   [Full Text] [Related]  

  • 42. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
    Tan O; Harman SM; Naftolin F
    Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with use of hormone therapy among women with mobility impairments.
    Yang K; Becker H; Dormire S
    Women Health; 2006; 43(1):19-36. PubMed ID: 17050483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An analysis of menopause in the popular press.
    Carlson ES; Li S; Holm K
    Health Care Women Int; 1997; 18(6):557-64. PubMed ID: 9416039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Care of the menopausal patient: a nurse practitioner's view.
    Dehn B
    J Am Acad Nurse Pract; 2007 Aug; 19(8):427-37. PubMed ID: 17655572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
    Hing E; Brett KM
    Obstet Gynecol; 2006 Jul; 108(1):33-40. PubMed ID: 16816053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hormone therapy dilemma: women respond.
    Breslau ES; Davis WW; Doner L; Eisner EJ; Goodman NR; Meissner HI; Rimer BK; Rossouw JE
    J Am Med Womens Assoc (1972); 2003; 58(1):33-43. PubMed ID: 12553641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Socioeconomic factors in menopausal women's use of hormone replacement therapy.
    Schbley BH
    J Women Aging; 2009; 21(2):99-110. PubMed ID: 19418341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey.
    Kaufert P; Boggs PP; Ettinger B; Woods NF; Utian WH
    Menopause; 1998; 5(4):197-202. PubMed ID: 9872483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts.
    Fournier A; Kernaleguen C; Panjo H; Clavel-Chapelon F; Ringa V
    Menopause; 2011 Feb; 18(2):219-23. PubMed ID: 21052030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Women's Health Initiative. Implications for practice.
    Furniss K
    Adv Nurse Pract; 2002 Nov; 10(11):53-5. PubMed ID: 12478949
    [No Abstract]   [Full Text] [Related]  

  • 58. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormone therapy following the Women's Health Initiative (WHI) study: perception of gynecologists in Brazil.
    Machado RB; Fernandes CE; Maia E; Melo NR; Baracat EC
    Minerva Ginecol; 2005 Oct; 57(5):563-8. PubMed ID: 16205602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A profile of skin cancer prevention media coverage in 2009.
    Cokkinides V; Kirkland D; Andrews K; Sullivan K; Lichtenfeld JL
    J Am Acad Dermatol; 2012 Oct; 67(4):570-5. PubMed ID: 22237018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.